J Philip Karl1, Claire E Berryman1,2,3, Melissa N Harris4, Harris R Lieberman1, Kishore M Gadde4, Jennifer C Rood4, Stefan M Pasiakos1. 1. Military Nutrition Division, US Army Research Institute of Environmental Medicine, Natick, MA, USA. 2. Oak Ridge Institute for Science and Education, Belcamp, MD, USA. 3. Department of Nutrition, Food, and Exercise Sciences, Florida State University, Tallahassee, FL, USA. 4. Louisiana State University's Pennington Biomedical Research Center, Baton Rouge, LA, USA.
Abstract
BACKGROUND: Severe energy deficits cause interrelated reductions in testosterone and fat free mass. Testosterone supplementation may mitigate those decrements, but could also reduce circulating concentrations of the orexigenic hormone ghrelin, thereby exacerbating energy deficit by suppressing appetite. OBJECTIVE: To determine whether testosterone supplementation during severe energy deficit influences fasting and postprandial ghrelin concentrations and appetite. DESIGN AND METHODS: Secondary analysis of a randomized, double-blind trial that determined the effects of testosterone supplementation on body composition changes during and following severe energy deficit in nonobese, eugonadal men. Phase 1 (PRE-ED): 14-day run-in; phase 2: 28 days, 55% energy deficit with 200 mg testosterone enanthate weekly (TEST; n = 24) or placebo (PLA; n = 26); phase 3: free-living until body mass recovered (end-of-study; EOS). Fasting and postprandial acyl ghrelin and des-acyl ghrelin concentrations and appetite were secondary outcomes measured during the final week of each phase. RESULTS: Fasting acyl ghrelin concentrations, and postprandial acyl and des-acyl ghrelin concentrations increased in PLA during energy deficit then returned to PRE-ED values by EOS, but did not change in TEST (phase-by-group, P < 0.05). Correlations between changes in free testosterone and changes in fasting acyl ghrelin concentrations during energy deficit (ρ = -0.42, P = 0.003) and body mass recovery (ρ = -0.38; P = 0.01) were not mediated by changes in body mass or body composition. Transient increases in appetite during energy deficit were not affected by testosterone treatment. CONCLUSIONS: Testosterone supplementation during short-term, severe energy deficit in healthy men prevents deficit-induced increases in circulating ghrelin without blunting concomitant increases in appetite. CLINICAL TRIALS REGISTRATION: www.clinicaltrials.gov NCT02734238 (registered 12 April 2016). Published by Oxford University Press on behalf of the Endocrine Society 2020.
BACKGROUND: Severe energy deficits cause interrelated reductions in testosterone and fat free mass. Testosterone supplementation may mitigate those decrements, but could also reduce circulating concentrations of the orexigenic hormone ghrelin, thereby exacerbating energy deficit by suppressing appetite. OBJECTIVE: To determine whether testosterone supplementation during severe energy deficit influences fasting and postprandial ghrelin concentrations and appetite. DESIGN AND METHODS: Secondary analysis of a randomized, double-blind trial that determined the effects of testosterone supplementation on body composition changes during and following severe energy deficit in nonobese, eugonadal men. Phase 1 (PRE-ED): 14-day run-in; phase 2: 28 days, 55% energy deficit with 200 mg testosterone enanthate weekly (TEST; n = 24) or placebo (PLA; n = 26); phase 3: free-living until body mass recovered (end-of-study; EOS). Fasting and postprandial acyl ghrelin and des-acyl ghrelin concentrations and appetite were secondary outcomes measured during the final week of each phase. RESULTS: Fasting acyl ghrelin concentrations, and postprandial acyl and des-acyl ghrelin concentrations increased in PLA during energy deficit then returned to PRE-ED values by EOS, but did not change in TEST (phase-by-group, P < 0.05). Correlations between changes in free testosterone and changes in fasting acyl ghrelin concentrations during energy deficit (ρ = -0.42, P = 0.003) and body mass recovery (ρ = -0.38; P = 0.01) were not mediated by changes in body mass or body composition. Transient increases in appetite during energy deficit were not affected by testosterone treatment. CONCLUSIONS: Testosterone supplementation during short-term, severe energy deficit in healthy men prevents deficit-induced increases in circulating ghrelin without blunting concomitant increases in appetite. CLINICAL TRIALS REGISTRATION: www.clinicaltrials.gov NCT02734238 (registered 12 April 2016). Published by Oxford University Press on behalf of the Endocrine Society 2020.
Authors: Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; J Carl Pallais; Elaine W Yu; Lawrence F Borges; Brent F Jones; Christopher V Barry; Kendra E Wulczyn; Bijoy J Thomas; Benjamin Z Leder Journal: N Engl J Med Date: 2013-09-12 Impact factor: 91.245
Authors: Lee M Margolis; Jennifer Rood; Catherine Champagne; Andrew J Young; John W Castellani Journal: Appl Physiol Nutr Metab Date: 2013-04-03 Impact factor: 2.665
Authors: A M Wren; L J Seal; M A Cohen; A E Brynes; G S Frost; K G Murphy; W S Dhillo; M A Ghatei; S R Bloom Journal: J Clin Endocrinol Metab Date: 2001-12 Impact factor: 5.958
Authors: Priya Sumithran; Luke A Prendergast; Elizabeth Delbridge; Katrina Purcell; Arthur Shulkes; Adamandia Kriketos; Joseph Proietto Journal: N Engl J Med Date: 2011-10-27 Impact factor: 91.245
Authors: Stefan M Pasiakos; Claire E Berryman; J Philip Karl; Harris R Lieberman; Jeb S Orr; Lee M Margolis; John A Caldwell; Andrew J Young; Monty A Montano; William J Evans; Oshin Vartanian; Owen T Carmichael; Kishore M Gadde; Neil M Johannsen; Robbie A Beyl; Melissa N Harris; Jennifer C Rood Journal: EBioMedicine Date: 2019-07-27 Impact factor: 8.143
Authors: Alyssa N Varanoske; Melissa N Harris; Callie Hebert; Emily E Howard; Neil M Johannsen; Steven B Heymsfield; Frank L Greenway; Lee M Margolis; Harris R Lieberman; Robbie A Beyl; David D Church; Arny A Ferrando; Stefan M Pasiakos; Jennifer C Rood Journal: J Appl Physiol (1985) Date: 2022-07-07
Authors: Alyssa N Varanoske; Melissa N Harris; Callie Hebert; Emily E Howard; Neil M Johannsen; Steven B Heymsfield; Frank L Greenway; Lee M Margolis; Harris R Lieberman; David D Church; Arny A Ferrando; Jennifer C Rood; Stefan M Pasiakos Journal: Contemp Clin Trials Commun Date: 2021-07-03